Exeter

This study is looking at a pathway using the CanRisk assessment tool to assess breast cancer risk. The team are comparing this pathway to the usual pathway

This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the pelvis.

This study is looking at blood and urine samples to try to pick up liver cancer earlier.

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This trial is looking at aspirin to try and reduce the risk of cancer for people with primary sclerosing cholangitis and inflammatory bowel disease.

This study is looking at blood samples and MRI scans to pick up liver cancer earlier.

This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.

This trial is looking at improving treatment for bowel cancer. It’s for people who have locally advanced bowel cancer with a gene change called BRAFV600E.

This study is looking at the amount of muscle and fat in the body and how it might affect the side effects of chemotherapy.